FIELD: biotechnology.
SUBSTANCE: present invention relates to fungi luciferin biosynthesis proteins. Invention discloses new enzymes for fungal luciferin biosynthesis and nucleic acids coding them, use of proteins and nucleic acids in fungal luciferin biosynthesis. Disclosed are methods of producing luciferin and preluciferin fungi in systems in vitro and in vivo, as well as use of such substances as luminophors in various fields of science.
EFFECT: proposed are luciferin biosynthesis enzymes and their use.
57 cl, 25 ex, 6 tbl, 9 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| CAFFEYLPYRUVATE HYDROLASES AND THEIR USE | 2020 |
|
RU2812474C2 |
| HISPIDIN SYNTHASES AND THEIR USE | 2020 |
|
RU2809367C2 |
| TYPE III POLYKETIDE SYNTHASES AND USE THEREOF | 2020 |
|
RU2822532C2 |
| METHODS AND PRODUCTS FOR PRODUCING AND DELIVERING NUCLEIC ACIDS | 2015 |
|
RU2714404C2 |
| IMMUNOCYTOKINES BASED ON IL-15 AND IL-15Rα OF THE SUSHI DOMAIN | 2012 |
|
RU2763298C2 |
| MULTIMERIZING POLYPEPTIDES DERIVED FROM DOMAIN WITH ROLL-TYPE PENTONE BASE OF ADENOVIRUS | 2019 |
|
RU2820522C2 |
| HPV-SPECIFIC BINDING MOLECULES | 2018 |
|
RU2804664C2 |
| MUTATIONS IN OAS1 GENES | 2006 |
|
RU2465328C2 |
| COMPOSITIONS CONTAINING CURONES AND WAYS OF APPLICATION THEREOF | 2018 |
|
RU2822800C2 |
| CD123-SPECIFIC CHIMERIC ANTIGENIC RECEPTORS FOR CANCER IMMUNOTHERAPY | 2015 |
|
RU2727290C2 |
